Promising gene therapy against hemophilia rejected by FDA By: San Francisco Business Times via Business Journals August 19, 2020 at 12:10 PM EDT BioMarin had gone so far as to give its hemophilia A gene therapy a name. Now it will have to deliver more data to the FDA. Read More >>
